{
    "code": "02023577",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023577",
    "time": "2020-02-25 13:09:43",
    "許可證字號": "衛署藥輸字第023577號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/06\/03",
    "註銷理由": "許可證已逾有效期",
    "製造許可登錄編號": "",
    "有效日期": "101\/10\/30",
    "發證日期": "91\/10\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202357700",
    "中文品名": "惠妥滋持續性藥效膠囊１２５公絲",
    "英文品名": "VIDEX EC DELAYED-RELEASE CAPSULES 125MG",
    "適應症": "治療受HIV感染的成人患者。",
    "劑型": "133持續性藥效膠囊劑",
    "包裝": "2-1000顆塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DIDANOSINE",
    "限制項目": "02輸　入",
    "申請商名稱": "1404501100  臺灣必治妥施貴寶股份有限公司",
    "申請商地址": "台北市松山區健康路156號4樓、5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FUS0121000  BRISTOL-MYERS SQUIBB COMPANY",
            "製造廠廠址": "2400 WEST LLOYD EXPRESSWAY,EVANSVILLE INDIANA 47721 U.S.A",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "CCC號列": "30049072004 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818000900",
            "成分名稱": "DIDANOSINE",
            "含量描述": "",
            "含量": "125.0000000000",
            "單位": "MG"
        }
    ]
}